先天性心脏病合并葡萄糖-6-磷酸脱氢酶缺乏症患儿药学监护

Pharmaceutical Care for A Child with Congenital Heart Disease Combined with Glucose-6-Phosphate Dehydrogenase Deficiency

临床药师参与1例先天性心脏病合并葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症患儿的药物治疗过程,探讨和分析该患儿使用双嘧达莫的安全性和有效性。临床药师参与制定个体化给药方案,在患儿药物治疗过程中开展药学监护,确保患儿合理用药。患儿经治疗后恢复良好,随访6个月以来未发生血栓栓塞事件,且未出现急性溶血性贫血及相关药品不良反应。临床药师将药学理论和循证药学知识与临床实践相结合,协助临床医师优化药物治疗方案,提高药物治疗安全性和有效性。

The safety and efficacy of dipyridamole in a child with congenital heart disease combined with Glucose-6-phosphate dehydrogenase(G6 PD)deficiency were analyzed.Clinical pharmacists participated in developing personalized medication regimen,provided pharmaceutical care,and ensured rational drug use of the child.After treatment,the patients recovered well.No thromboembolic events occurred during the 6-month follow-up,and no acute hemolytic anemia and related adverse drug reactions occurred.Clinical pharmacists properly combine the theoretic knowledge and evidence-based medicine in clinical practice to assist clinicians to optimize drug treatment programs and improve the safety and effectiveness of drug treatment.